- Aurora Cannabis Achieves Australia's TGA GMP Certification, Setting Global Standard for Quality and Compliance
- Aurora Introduces Medical Cannabis Pastilles for Patient Relief in Australia
- Aurora Completes Final Repayment of Convertible Senior Notes Representing ~$465 Million in Total Repayments Since 2021; Cannabis Operations Are Now Debt Free[1]
- Aurora Partners with Script Assist to Provide Better Access to UK Medical Cannabis
- Aurora Cannabis Announces CFO Transition and Completion of Previously Announced Share Consolidation
- Aurora Cannabis Announces Fiscal 2024 Third Quarter Results; Generates Record Adjusted EBITDA of $4.3 Million
- Aurora Cannabis Acquires MedReleaf Australia
- Aurora Cannabis Provides Business Update and Announces Date of Third Quarter Fiscal Year 2024 Investor Conference Call
- Aurora Unveils Innovative Cannabis-Infused Ready-to-Drink Beverage in Latest Medical Product Launch
More ▼
Key statistics
On Thursday, Aurora Cannabis Inc (ACB:TOR) closed at 5.93, 54.43% above the 52 week low of 3.84 set on Mar 14, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 6.29 |
---|---|
High | 6.74 |
Low | 5.83 |
Bid | 5.93 |
Offer | 5.95 |
Previous close | 6.44 |
Average volume | 2.21m |
---|---|
Shares outstanding | 54.54m |
Free float | 54.53m |
P/E (TTM) | -- |
Market cap | 351.23m CAD |
EPS (TTM) | -3.39 CAD |
Data delayed at least 15 minutes, as of Mar 28 2024 20:00 BST.
More ▼